Research theme for competitive and other funds (7):
2022 - 2025 A study on clinical implementation of response guided therapy with neoadjuvant endocrine therapy for breast cancer.
2018 - 2021 New predictive markers of effectiveness of neoadjuvant endocrine therapy of breast cancer by analyzing tumor angiogenesis
2016 - 2020 Treatment strategy for suppression of cancer stem cell in breast cancer
2008 - 2012 EB virus-associated gastric carcinoma. Molecular mechanisms of DNA hypermethylation and strategy for gastric cancer therapy.
2009 - 2010 乳癌におけるマイクロRNA発現制御機構の解明
2007 - 2008 Molecular Mechanism for Regulation of microRNA Expression in Gastrointestinal Cancer
2006 - 2007 Carcinogenesis of EB virus-associated gastric carcinoma. Mutual DNA-methylation of host and infective agent.
Show all
Papers (104):
Fumihiko Ando, Takeru Kashiwada, Shoko Kuroda, Takenori Fujii, Ryotaro Takano, Yoshishige Miyabe, Shinobu Kunugi, Takashi Sakatani, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, et al. Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer. Frontiers in Pharmacology. 2024. 15
Hideko Hoshina, Takashi Sakatani, Yoko Kawamoto, Ryuji Ohashi, Hiroyuki Takei. Cytomorphological disparities in invasive breast cancer cells following neoadjuvant endocrine therapy and chemotherapy. Pathobiology : journal of immunopathology, molecular and cellular biology. 2024